Atlas Trials

Study on the Effects of Sacubitril/Valsartan on Physical Activity and Sleep in Heart Failure With Reduced Ejection Fraction Patients.

Clinical trial NCT02970669 · COMPLETED

Trial details

NCT number
NCT02970669
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Heart Failure, Reduced Ejection Fraction
Start date
2016-12-16
Primary completion
2018-03-19
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.